Literature DB >> 12865464

p73 Overexpression and angiogenesis in human colorectal carcinoma.

Ming Guan1, Hai-Xia Peng, Bo Yu, Yuan Lu.   

Abstract

BACKGROUND: Solid tumors requires neovascularization for growth and metastasis. Angiogenesis depends on the local balance between positive and negative effectors, the production of which can be regulated by oncogenes and tumor suppressor genes. The aim of this study was to investigate expression of p73, a gene homologous to the tumor suppressor gene p53, in colorectal cancer and its relationship to angiogenesis.
METHODS: p73 expression was examined by immunohistochemistry and western blot analysis on 56 primary colon carcinomas with matched normal mucosas. Vascular endothelial growth factor (VEGF) and microvessels were highlighted using a monoclonal antibody specific to VEGF and von Willebrand factor (vWF).
RESULTS: The immunoexpressions of p73 were significantly higher in the primary colorectal carcinomas than that in the matched normal mucosa (P < 0.001). Western blotting showed that 85% patients have a high level of p73 expression (more than double the normal level). A close association between p73 and VEGF expression level was observed (P = 0.016). Colorectal adenocarcinoma that expressed p73 showed significantly greater vascularity than p73-negative tumors (P = 0.012). However, no association between immunoexpression of p73 and tumor stage or differentiation was observed.
CONCLUSION: These findings suggest a potential role of p73 in tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865464     DOI: 10.1093/jjco/hyg045

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  15 in total

1.  Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients.

Authors:  Amira Toumi Arfaoui; Lilia Ben Mahmoud Kriaa; Olfa El Amine El Hadj; Majid A Ben Hmida; Myriam Khiari; T Khalfallah; Lasaad Gharbi; Sabeh Mzabi; Sadaa Bouraoui
Journal:  Virchows Arch       Date:  2010-07-20       Impact factor: 4.064

2.  Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk.

Authors:  Lan Wang; Rui Gao; Long Yu
Journal:  Mol Biol Rep       Date:  2011-05-27       Impact factor: 2.316

3.  Aberrant expression of DeltaNp73 in benign and malignant tumours of the prostate: correlation with Gleason score.

Authors:  M Guan; Y Chen
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

4.  TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activity.

Authors:  Marina Stantic; Habib A M Sakil; Hanna Zirath; Trixy Fang; Gema Sanz; Alejandro Fernandez-Woodbridge; Ana Marin; Evelyn Susanto; Tak W Mak; Marie Arsenian Henriksson; Margareta T Wilhelm
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

5.  p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling.

Authors:  R Fernandez-Alonso; M Martin-Lopez; L Gonzalez-Cano; S Garcia; F Castrillo; I Diez-Prieto; A Fernandez-Corona; M E Lorenzo-Marcos; X Li; L Claesson-Welsh; M M Marques; M C Marin
Journal:  Cell Death Differ       Date:  2015-01-09       Impact factor: 15.828

6.  Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.

Authors:  Pinelopi Nterma; Eleni Panopoulou; Eleni Papadaki-Petrou; Martha Assimakopoulou
Journal:  Pathol Oncol Res       Date:  2019-01-02       Impact factor: 3.201

7.  Association between TAp73, p53 and VASH1 expression in lung adenocarcinoma.

Authors:  Meng Wu; Zhihua Zhang; Fangxu Ma; Xiulong Zhang; Zhilin Zhang; Jianhua Tang; Ping Chen; Chunyan Zhou; Weiping Wang
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

8.  p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck.

Authors:  Fanglin Li; Erich M Sturgis; Mark E Zafereo; Zhensheng Liu; Li-E Wang; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

9.  p53 Family: Role of Protein Isoforms in Human Cancer.

Authors:  Jinxiong Wei; Elena Zaika; Alexander Zaika
Journal:  J Nucleic Acids       Date:  2011-10-09

10.  p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.

Authors:  Chaitali Tophkhane; Shi-He Yang; Yunbo Jiang; Zhikun Ma; Dharmalingam Subramaniam; Shrikant Anant; Shingo Yogosawa; Toshiyuki Sakai; Wan-Guo Liu; Susan Edgerton; Ann Thor; Xiaohe Yang
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.